- Home
- ESAB vs ICLR Comparison
ESAB vs ICLR Comparison
Compare ESAB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESAB | ICLR |
|---|---|---|
| Founded | 1904 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.1B |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ESAB | ICLR |
|---|---|---|
| Price | $108.28 | $107.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $144.13 | ★ $194.38 |
| AVG Volume (30 Days) | 430.0K | ★ 3.4M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.67 | N/A |
| Revenue | ★ $2,842,555,000.00 | N/A |
| Revenue This Year | $6.42 | N/A |
| Revenue Next Year | $5.59 | N/A |
| P/E Ratio | $30.97 | ★ $12.91 |
| Revenue Growth | ★ 3.71 | N/A |
| 52 Week Low | $100.17 | $66.57 |
| 52 Week High | $137.42 | $211.00 |
Technical Indicators
Market Signals| Indicator | ESAB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 29.01 | 36.39 |
| Support Level | N/A | $66.57 |
| Resistance Level | $118.33 | $153.72 |
| Average True Range (ATR) | 4.40 | 5.42 |
| MACD | -2.51 | 3.15 |
| Stochastic Oscillator | 2.45 | 74.62 |
Price Performance
Historical ComparisonAbout ESAB ESAB Corporation
ESAB, spun off from Colfax in 2022, is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications. Alongside competitors Lincoln Electric and ITW's Miller brand, ESAB is one of the top three players in the welding space. ESAB generated roughly $2.7 billion in revenue in 2024.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.